Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Harmony Biosciences Q2 2024 Adj. EPS $1.05 Beats $(0.06) Estimate, Sales $172.814M Miss $173.098M Estimate

Author: Benzinga Newsdesk | August 06, 2024 07:46am
Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $1.05 per share which beat the analyst consensus estimate of $(0.06) by 1850 percent. This is a 38.16 percent increase over earnings of $0.76 per share from the same period last year. The company reported quarterly sales of $172.814 million which missed the analyst consensus estimate of $173.098 million by 0.16 percent. This is a 28.76 percent increase over sales of $134.216 million the same period last year.

Posted In: HRMY


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist